Product search
Filter
Search results
Edoxaban (Lixiana®) Control
For the quality control of edoxaban measurements using anti-Xa chromogenic assays.
Edoxaban (Lixiana®) Control Low
For the quality control of edoxaban measurements using anti-Xa chromogenic assays.
Edoxaban Calibrator (Lixiana®) Low
For the calibration of edoxaban measurements using anti-Xa chromogenic assays.
Emicizumab Calibrator
Calibration of a modified one-stage FVIII activity assay for determination of active emicizumab concentration from a clot time measurement performed on an automated coagulation analyzer.
Emicizumab Controls
Quality control of a modified one-stage FVIII activity assay for determination of active emicizumab concentration from a clot time measurement performed on an automated coagulation analyzer.
Epinephrine
Investigation of congenital (e.g., Glanzmann’s thrombasthenia, gray platelet syndrome) or acquired thrombopathy (e.g. myelodisplasic or myeloproliferative syndrome, Waldenström’s disease, multiple myeloma). Follow-up of patients treated with antiplatelet drugs such as aspirin, thienopyridines, abciximab and other NSAIDsand GPIIb/IIIa inhibitors.
FIBRIPHEN™ LRT
Clotting method for quantitative determination of fibrinogen (Clauss method)
FII Inhibitor Plasma (1) mild (1-10 BU/ml), frozen
Can be used as a substitute for plasmas from patients that have developed neutralizing antibodies to coagulation factors. For research use only.
FIX Inhibitor Plasma (1) mild (1-10 BU/ml), frozen
Can be used as a substitute for plasmas from patients that have developed neutralizing antibodies to coagulation factors. For research use only.
FIX Inhibitor Plasma (1) mild (1-10 BU/ml), lyophilized
Can be used as a substitute for plasmas from patients that have developed neutralizing antibodies to coagulation factors. For research use only.